<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 1 Issue 4</issue_number>
<issue_period>2010 (October - December)</issue_period>
<title>Clinical Analysis, Drug Designing And QSAR Studies On Rheumatoid Arthritis</title>
<abstract>The clinical data related to Rheumatoid Arthritis has shown that there is more number of males (60%) than females (40%) during January month at KGH, Visakhapatnam, India. The patients also have more number of Neutrophils (72%) and Lymphocytes (18%) and less number of Eosinophils (10%) and Monocytes (0%) suffering from Rheumatoid Arthritis. Based on docking results Leflunomide and Desoxycorticosterone Pivalate shown good results based on distance approach (43.5) against RA. Based on Emin values, Auranofin (-66.73) has shown good activity compared with other selected drugs. Based on QSAR analysis Cyclosporine and Phenacetin are related and also shown similar results with docking. </abstract>
<authors>D.S.V.G.K.Kaladhar, K.V.V.V.Satyanarayana, A.Krishna Chaitanya, S.A.K.Zakir Hussain</authors>
<keywords>Rheumatoid Arthritis, QSAR. </keywords>
<pages>132-138</pages>
</article>
</Journal>
